Dimitrios Tzourmakliotis

Outcome of Hepatitis B e Antigen–Negative Chronic Hepatitis B on Long-Term Nucleos(t)ide Analog Therapy Starting With Lamivudine *

George Papatheodoridis, Evangelini Dimou, Konstantinos Dimakopoulos et al. · Hepatology · 2005 · 218 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen–negative chronic hepatitis B virus infection?

George Papatheodoridis, Emanuel K. Manesis, Spilios Manolakopoulos et al. · Hepatology · 2008 · 131 citations · Full text

Medicine, Infectious Diseases, Pathology +17

Does clinical response correlate with mucosal healing in patients with Crohnʼs disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy

Alkiviadis Efthymiou, Nikos Viazis, Gerassimos J. Mantzaris et al. · Inflammatory Bowel Diseases · 2008 · 118 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension

Spilios Manolakopoulos, Christos Triantos, Jiannis Theodoropoulos et al. · Journal of Hepatology · 2009 · 108 citations

Medicine, Internal Medicine, Pharmacotherapy +14

Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: A multicenter randomized controlled trial

Spilios Manolakopoulos, Alec Avgerinos, Anastasios Armonis et al. · Gastrointestinal Endoscopy · 2002 · 74 citations

Medicine, Clinical Sciences, Pharmacotherapy +13